Threat Scenarios for Pharmaceutical Manufacturers
International price differences, for instance, create an economic incentive for re-imports. As a result, a pharmaceutical product purchased abroad at a lower price may for example be sold in the United States or Germany at a higher price. In a practice commonly known as dumpster diving, fraudsters look for empty medicine containers in dumpsters to fill them with counterfeit substances. Conventionally labeled containers may thus be put into circulation and passed off as originals without their fraudulent use being readily discernible. To put a stop to such threat scenarios, pharmaceutical companies are subject to numerous regulations. Commonly applicable to the industry are the “Good Manufacturing Practices “(GMP) and the “Good Distribution Practices” (GDP) which describe the general conditions to be observed in quality management. In addition, there are national pharmaceutical laws, European regulations and directives, as well as the “E-Pedigree” requirement in the United States.
Customized Security Labels as a Viable Solution
Fundamental industry knowledge combined with specialized marking know-how is the prerequisite for developing tamper-protection and anti-counterfeiting solutions for the pharmaceutical industry. Effective security solutions with customized value-added functions can be divided into three categories, depending on the specific threat scenarios: Labels indicate first opening and tampering, they protect against counterfeiting or serve identification and tracking purposes through integrated track & trace system solutions. All the features can be customized and combined with each other. This results in complex security labels that successfully put a stop to the counterfeiters’ game.